This CE highlights the discussions and insights focused on the intricate dynamics of drug-to-drug (DDI), drug-to-cannabis (DTCI) interactions, cannabis contamination, and methodologies to improve health outcomes in practice for effective treatment.
The webinar provides a comprehensive overview of interactions between medications and cannabis, shedding light on the mechanisms underlying DDI and DTCI. Attendees will gain insights into the interactions between various pharmaceuticals and cannabis, with a particular emphasis on the potential implications for patient safety and therapeutic efficacy. Outcomes will help with how cannabis and specific components within cannabis (e.g., THC, CBD, etc.) may alter the levels and duration of other medications allowing physicians to adjust dosing
Goal: Clinical Professionals in the fields of medicine, pharmacy and other health related fields demonstrate competency in cannabis drug interactions to mitigate complications, improve health outcomes and reduce stigma for their patients
Continuing Education Information: 1.0 Category 1 CHES Credits, 1.0 Continuing Competency
